Q1 Earnings Forecast for STOK Issued By Leerink Partnrs
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Stoke Therapeutics in a note issued to investors on Tuesday, March 18th. Leerink Partnrs analyst M. Goodman expects that the company will post earnings of ($0.49) per share for the quarter. The consensus estimate for Stoke […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Stoke Therapeutics in a note issued to investors on Tuesday, March 18th. Leerink Partnrs analyst M. Goodman expects that the company will post earnings of ($0.49) per share for the quarter. The consensus estimate for Stoke […]
